These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25664465)

  • 41. Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.
    Pinto TCC; Machado L; Costa MLG; Santos MSP; Bulgacov TM; Rolim APP; Silva GA; Rodrigues-Júnior AL; Sougey EB; Ximenes RCC
    Dement Geriatr Cogn Disord; 2019; 47(4-6):366-374. PubMed ID: 31466064
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Global clinical dementia rating of 0.5 in MCI masks variability related to level of function.
    Chang YL; Bondi MW; McEvoy LK; Fennema-Notestine C; Salmon DP; Galasko D; Hagler DJ; Dale AM;
    Neurology; 2011 Feb; 76(7):652-9. PubMed ID: 21321338
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Psychometric Properties of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson's Disease.
    Gallagher J; Rick J; Xie SX; Martinez-Martin P; Mamikonyan E; Chen-Plotkin A; Dahodwala N; Morley J; Duda JE; Trojanowski JQ; Siderowf A; Weintraub D
    J Parkinsons Dis; 2021; 11(2):737-745. PubMed ID: 33386814
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Validity of a short computerized assessment battery for moderate cognitive impairment and dementia.
    Dwolatzky T; Dimant L; Simon ES; Doniger GM
    Int Psychogeriatr; 2010 Aug; 22(5):795-803. PubMed ID: 20519066
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differentiation between mild cognitive impairment and Alzheimer's disease using the FMLL mini-battery.
    Abizanda P; López-Ramos B; Romero L; Sánchez-Jurado PM; León M; Martín-Sebastiá E; López-Jiménez E
    Dement Geriatr Cogn Disord; 2009; 28(2):179-86. PubMed ID: 19713701
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of cognitive impairment and comorbidity on disability in hospitalized elderly patients.
    Orsitto G; Cascavilla L; Franceschi M; Aloia RM; Greco A; Paris F; Seripa D; Pilotto A
    J Nutr Health Aging; 2005; 9(3):194-8. PubMed ID: 15864400
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic performance of an Executive Clock Drawing Task (CLOX) as a screening test for mild cognitive impairment in elderly persons with cognitive complaints.
    Forti P; Olivelli V; Rietti E; Maltoni B; Ravaglia G
    Dement Geriatr Cogn Disord; 2010; 30(1):20-7. PubMed ID: 20606441
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impaired Cognitive Function is Associated with Motor Function and Activities of Daily Living in Mild to Moderate Alzheimer's Dementia.
    Lee G
    Curr Alzheimer Res; 2020; 17(7):680-686. PubMed ID: 32811414
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cross-cultural adaptation and validation of the Amsterdam Instrumental Activities of Daily Living questionnaire short version German for Switzerland.
    Bruderer-Hofstetter M; Dubbelman MA; Meichtry A; Koehn F; Münzer T; Jutten RJ; Scheltens P; Sikkes SAM; Niedermann K
    Health Qual Life Outcomes; 2020 Oct; 18(1):323. PubMed ID: 33008394
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Importance of a functional measure in the evaluation of patients in a memory clinic: Validation of the Serbian version of the Amsterdam instrumental activities of daily living questionnaire.
    Milošević V; Malobabić M; Stojanović I; Bašić J
    Clin Neurol Neurosurg; 2022 Mar; 214():107165. PubMed ID: 35149261
    [TBL] [Abstract][Full Text] [Related]  

  • 51. How Do Scores on the ADAS-Cog, MMSE, and CDR-SOB Correspond?
    Balsis S; Benge JF; Lowe DA; Geraci L; Doody RS
    Clin Neuropsychol; 2015; 29(7):1002-9. PubMed ID: 26617181
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Latent information in fluency lists predicts functional decline in persons at risk for Alzheimer disease.
    Clark DG; Kapur P; Geldmacher DS; Brockington JC; Harrell L; DeRamus TP; Blanton PD; Lokken K; Nicholas AP; Marson DC
    Cortex; 2014 Jun; 55():202-18. PubMed ID: 24556551
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.
    Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A;
    J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655
    [TBL] [Abstract][Full Text] [Related]  

  • 54. δ Scores Identify Subsets of "Mild Cognitive Impairment" with Variable Conversion Risks.
    Royall DR; Palmer RF
    J Alzheimers Dis; 2019; 70(1):199-210. PubMed ID: 31127788
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Japanese version of the Frontal Assessment Battery for dementia.
    Kugo A; Terada S; Ata T; Ido Y; Kado Y; Ishihara T; Hikiji M; Fujisawa Y; Sasaki K; Kuroda S
    Psychiatry Res; 2007 Sep; 153(1):69-75. PubMed ID: 17599465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spanish version of the Bayer Activities of Daily Living scale in mild cognitive impairment and mild Alzheimer disease: discriminant and concurrent validity.
    Sánchez-Benavides G; Manero RM; Quiñones-Ubeda S; de Sola S; Quintana M; Peña-Casanova J
    Dement Geriatr Cogn Disord; 2009; 27(6):572-8. PubMed ID: 19602885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activities of daily living in frontotemporal dementia and Alzheimer disease.
    Mioshi E; Kipps CM; Dawson K; Mitchell J; Graham A; Hodges JR
    Neurology; 2007 Jun; 68(24):2077-84. PubMed ID: 17562828
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuropsychiatric Symptoms in Alzheimer's Disease Are the Main Determinants of Functional Impairment in Advanced Everyday Activities.
    Delgado C; Vergara RC; Martínez M; Musa G; Henríquez F; Slachevsky A
    J Alzheimers Dis; 2019; 67(1):381-392. PubMed ID: 30584142
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Depression and frontal dysfunction: risks for the elderly?].
    Thomas P; Hazif Thomas C; Billon R; Peix R; Faugeron P; Clément JP
    Encephale; 2009 Sep; 35(4):361-9. PubMed ID: 19748373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.